Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients.

CYP2C19 CYP2D6 OCT1 SLC22A1 amitriptyline drug transport nortriptyline organic cation transporter 1

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2021
Historique:
received: 31 03 2021
accepted: 04 05 2021
entrez: 7 6 2021
pubmed: 8 6 2021
medline: 8 6 2021
Statut: epublish

Résumé

The tricyclic antidepressant amitriptyline is frequently prescribed but its use is limited by its narrow therapeutic range and large variation in pharmacokinetics. Apart from interindividual differences in the activity of the metabolising enzymes cytochrome P450 (CYP) 2D6 and 2C19, genetic polymorphism of the hepatic influx transporter organic cation transporter 1 (OCT1) could be contributing to interindividual variation in pharmacokinetics. Here, the impact of OCT1 genetic variation on the pharmacokinetics of amitriptyline and its active metabolite nortriptyline was studied

Identifiants

pubmed: 34093211
doi: 10.3389/fphar.2021.688950
pii: 688950
pmc: PMC8175851
doi:

Types de publication

Journal Article

Langues

eng

Pagination

688950

Informations de copyright

Copyright © 2021 Matthaei, Brockmöller, Steimer, Pischa, Leucht, Kullmann, Jensen, Ouethy, Tzvetkov and Rafehi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Biochem Pharmacol. 2013 Sep 1;86(5):666-78
pubmed: 23835420
Pharmacol Rev. 2020 Jan;72(1):253-319
pubmed: 31852803
Neuropsychopharmacology. 2000 Apr;22(4):380-7
pubmed: 10700657
Drug Metab Pharmacokinet. 2005 Dec;20(6):452-77
pubmed: 16415531
Acta Psychiatr Scand. 2001 Sep;104(3):173-92
pubmed: 11531654
Genome Med. 2015 Jun 18;7(1):56
pubmed: 26157489
Clin Chem. 2005 Feb;51(2):376-85
pubmed: 15590749
J Pharm Sci. 2021 Jan;110(1):397-403
pubmed: 32898521
Biochem Pharmacol. 2012 May 15;83(10):1427-34
pubmed: 22342776
Clin Pharmacol Ther. 1983 Oct;34(4):516-20
pubmed: 6617075
PLoS One. 2013 Dec 16;8(12):e82459
pubmed: 24358186
Nature. 2011 Aug 31;477(7362):54-60
pubmed: 21886157
Mayo Clin Proc. 1979 Oct;54(10):669-74
pubmed: 39202
Obesity (Silver Spring). 2010 Sep;18(9):1695-700
pubmed: 20111019
Cleve Clin J Med. 2019 Dec;86(12):807-814
pubmed: 31821138
J Nutr. 2009 Jun;139(6):1073-81
pubmed: 19369366
Clin Pharmacol Ther. 2017 Jul;102(1):37-44
pubmed: 27997040
J Psychopharmacol. 2004 Mar;18(1):66-74
pubmed: 15107187
Pharm Res. 2018 Oct 25;35(12):243
pubmed: 30361780
Clin Pharmacol Ther. 2011 Jul;90(1):143-50
pubmed: 21562485
J Med Chem. 2021 Mar 11;64(5):2762-2776
pubmed: 33606526
J Psychiatr Res. 2007 Jan-Feb;41(1-2):179-88
pubmed: 16387324
Mol Psychiatry. 2004 May;9(5):442-73
pubmed: 15037866
J Pharmacol Exp Ther. 1988 May;245(2):455-9
pubmed: 2896792
Cochrane Database Syst Rev. 2015 Jul 06;(7):CD008242
pubmed: 26146793
Pharmacogenomics. 2000 May;1(2):125-51
pubmed: 11256586
Br J Pharmacol. 2007 Jul;151(6):737-48
pubmed: 17471183
Expert Rev Neurother. 2015 Oct;15(10):1123-50
pubmed: 26395929
Pak J Biol Sci. 2012 Sep 15;15(18):871-6
pubmed: 24205756
J Med Chem. 2008 Oct 9;51(19):5932-42
pubmed: 18788725
Clin Pharmacol Ther. 2019 Jan;105(1):190-200
pubmed: 29882324
Clin Transl Sci. 2020 Jan;13(1):116-124
pubmed: 31647186
JAMA Psychiatry. 2021 Mar 1;78(3):270-280
pubmed: 33237321
Clin Chem. 2004 Sep;50(9):1623-33
pubmed: 15205367
Pharmacopsychiatry. 2018 Jan;51(1-02):9-62
pubmed: 28910830
Cell Mol Neurobiol. 1999 Jun;19(3):373-409
pubmed: 10319193
Clin Pharmacol Ther. 2018 May;103(5):868-878
pubmed: 28791698
Pharmacogenomics. 2017 May;18(7):701-739
pubmed: 28480783
Anal Biochem. 1985 Oct;150(1):76-85
pubmed: 3843705
Naunyn Schmiedebergs Arch Pharmacol. 2012 Oct;385(10):1017-23
pubmed: 22806583
Mol Psychiatry. 2013 Mar;18(3):273-87
pubmed: 22565785
Drug Metab Dispos. 2007 Aug;35(8):1325-32
pubmed: 17470525
Pharmazie. 2018 Nov 1;73(11):619-624
pubmed: 30396378
Anal Chem. 2020 Jul 21;92(14):9745-9754
pubmed: 32551505
Pharmacol Rev. 1998 Sep;50(3):387-412
pubmed: 9755288
J Clin Psychopharmacol. 2008 Feb;28(1):78-83
pubmed: 18204346
AAPS PharmSci. 2002;4(4):E25
pubmed: 12645997
Clin Pharmacokinet. 2009;48(11):689-723
pubmed: 19817501
Int Clin Psychopharmacol. 1986 Apr;1(2):102-12
pubmed: 3571939
Drug Metab Rev. 2004 Oct;36(3-4):723-46
pubmed: 15554244
Neurochem Int. 1989;14(4):447-54
pubmed: 20504448
Clin Pharmacol Ther. 1998 Apr;63(4):444-52
pubmed: 9585799
Continuum (Minneap Minn). 2015 Aug;21(4 Headache):973-89
pubmed: 26252585

Auteurs

Johannes Matthaei (J)

Institute of Clinical Pharmacology, University Medical Center Göttingen, Georg-August University, Göttingen, Germany.

Jürgen Brockmöller (J)

Institute of Clinical Pharmacology, University Medical Center Göttingen, Georg-August University, Göttingen, Germany.

Werner Steimer (W)

Institute for Clinical Chemistry and Pathobiochemistry, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Konstanze Pischa (K)

Institute for Clinical Chemistry and Pathobiochemistry, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Stefan Leucht (S)

Section Evidence Based Medicine in Psychiatry and Psychotherapy, Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Maria Kullmann (M)

Institute of Clinical Pharmacology, University Medical Center Göttingen, Georg-August University, Göttingen, Germany.

Ole Jensen (O)

Institute of Clinical Pharmacology, University Medical Center Göttingen, Georg-August University, Göttingen, Germany.

Typhaine Ouethy (T)

Institute of Clinical Pharmacology, University Medical Center Göttingen, Georg-August University, Göttingen, Germany.

Mladen Vassilev Tzvetkov (MV)

Institute of Clinical Pharmacology, University Medical Center Göttingen, Georg-August University, Göttingen, Germany.
Institute of Pharmacology, Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald, Greifswald, Germany.

Muhammad Rafehi (M)

Institute of Clinical Pharmacology, University Medical Center Göttingen, Georg-August University, Göttingen, Germany.

Classifications MeSH